Pars Bioscience, LLC understands that scientific discovery starts with a VISION. Our small team of respected individuals is RESEARCHING ways to imporve life and cure common illness. SOECIALIZING in common, but under developed substances. Pars Bioscience has a mindset of QUALITY CONTROL and QUALITY ASSURANCE.
Delivering dependable healthcare origination worldwide is more challenging and complex than ever.
DISCOVER OUR RESEARCH PROJECTS
Proven strategies have resulted in groundbreaking results
Pars Bioscience, LLC is a Limited Corporation owned by Dr. Rafie Hamidpour, Ph.D. (Her is a co-inventor of Immunoglobulin (Anti-GPIIb/IIIa Antibody), which is register as a patent in PCT/UK.), Ms. Roxanna Hamidpour, Mr. Sam Hamidpour., Dr. Soheila Hamidpour, M.D. and Dr. Mohsen Hamidpour, PH.D.
We are a Kansas Corporation which has done research and development since 2004. The business has been doing research on Pharmacological studies that have demonstrated saffron extracts have anti-tumor effects and inhibit the growth of human cancer cells.
Dr. Hamidpour's vision to research medical treatments is the foundation for Pars Bioscience, LLC.
This business plan is being used to explore Investigation of Saffron as a Nutritional Supplement for use in Cancer Treatments. The purpose of this project is to investigate saffron, and the processes used to prepare it, as a nutritional supplement for use in treating cancer.
Initially, a literature review of saffron and its application in cancer treatment will be conducted. After literature review, different preparations of saffron will be analyzed as a nutritional supplement. Concentration of the main active components of saffron will also be determined for each preparation.
Pars Bioscience’s realized that traditional medicinal strategies are very attractive and have earned serious consideration as potential means of controlling the incidence of cancer and been used over thousand years on other countries.
An important element of anticancer drug development using herbs is the main core of our research. The aim of this research is to provide an updated overview of experimental in vitro and in vivo investigations focused on the anticancer activity of saffron (Crocus sativus L.) and its principal ingredients. Potential use of these natural agents in cancer therapy and chemo preventive trials is also discussed.